World PulseNow
Newsletter

The Download: the mysteries surrounding weight-loss drugs, and the economic effects of AI

MIT Technology Review•Friday, November 28, 2025 at 1:10:00 PM
NeutralArtificial Intelligence
The Download: the mysteries surrounding weight-loss drugs, and the economic effects of AI
  • Weight-loss drugs have gained attention recently, particularly with Eli Lilly's advancements in its products Mounjaro and Zepbound, which are designed to aid in weight management. The ongoing discussions highlight the complexities and uncertainties surrounding these medications, including their efficacy and potential side effects.
  • Eli Lilly's developments in weight-loss drugs are significant as they position the company at the forefront of a growing market, potentially impacting public health and consumer behavior. The success of these drugs could lead to increased sales and a stronger market presence for Eli Lilly in the pharmaceutical industry.
  • The conversation around weight-loss drugs is intertwined with broader economic themes, particularly the implications of artificial intelligence on healthcare and the economy. As AI continues to evolve, its influence on drug development and healthcare delivery raises questions about the future of medical treatments and the ethical considerations surrounding their use.
— via World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
The Download: AI’s impact on the economy, and DeepSeek strikes again
MIT Technology Review9 hours ago
The Download: AI’s impact on the economy, and DeepSeek strikes again
NeutralArtificial Intelligence
The latest edition of The Download from MIT Technology Review highlights the uneven adoption of generative AI and its significant impact on the economy, as discussed by David Rotman and Richard Waters. The newsletter emphasizes the ongoing debate regarding the optimistic versus pessimistic views on AI's economic effects.
Read full article
via MIT Technology Review
An interview with Google DeepMind Nobel laureate John Jumper on the creative "off-label" uses for AlphaFold, combining AlphaFold's power with LLMs, and more (Will Douglas Heaven/MIT Technology Review)
Techmeme3 days ago
An interview with Google DeepMind Nobel laureate John Jumper on the creative "off-label" uses for AlphaFold, combining AlphaFold's power with LLMs, and more (Will Douglas Heaven/MIT Technology Review)
PositiveArtificial Intelligence
John Jumper, a Nobel laureate from Google DeepMind, discussed innovative applications of AlphaFold, an AI system that predicts protein structures, in a recent interview. He highlighted the potential of combining AlphaFold's capabilities with large language models (LLMs) for creative uses beyond its original design. Jumper's insights reflect the ongoing evolution of AI technologies and their applications in various fields.
Read full article
via Techmeme